This information was published on 2020-04-03T12:17:36 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2060176 (IR 1506395) |
| (220) |
15 Oct 2019
|
| (300) |
BX, 17 May 2019, 01395914
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of cancer. |
| (540) | JIVADCO |
| (550) | Word |
| (730) |
Synthon Biopharmaceuticals B.V.
|
Find out more about publications on the About page.